A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) Patients

Name: A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) Patients
Published: 2012
License: Public Domain

Novartis Pharmaceuticals · 2012

ClinicalTrials.gov · Datasets · License: Public Domain · 2012

Open Source ↗

acute-myeloid-leukemia

myelodysplastic syndromes (mds), chronic myelomonocytic leukemia (cmml), acute myeloid leukemia (aml), myelodysplastic syndromes, mds, chronic myelomonocytic leukemia, cmml, acute myeloid leukemia, aml, panobinostat, lbh589, 5-aza

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 874468
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.